LSD microdosing reduces depression scores without major side effects, clinical trial finds

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...
pharmaphorum

FDA clears subcutaneous Keytruda in a boost to MSD

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
Hackaday

Programming The 6581 Sound Interface Device (SID) With The 6502

Over on YouTube, [Ben Eater] pursues that classic 8-bit sound. In this video, [Ben] integrates the MOS Technology 6581 Sound ...
pharmaphorum

MSD advances on a broad front with TL1A drug tulisokibart

MSD's confidence in its anti-TL1A antibody tulisokibart in inflammatory diseases has been made apparent by a decision to start trials of the drug in three more indications. Already in phase 3 testing ...